Yang Li

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Endoplasmic Reticulum Stress

Breast Cancer Cells

Cell Cycle Arrest

Top Venues

Journal of medicinal chemistry

Journal of Asian natural products research

This page only lists publications with an associated author ORCID identifier.

Publications

Juncheng Chen, Pan Tang, Yu-Xi Wang, Jiaxing Wang, Chengcan Yang, Yang Li, Gaoxia Yang, Fengbo Wu, Jifa Zhang, Liang Ouyang
Targeting Bromodomain-Selective Inhibitors of BET Proteins in Drug Discovery and Development. Journal of medicinal chemistry 65 (7) (2022)
Jifa Zhang, Chengcan Yang, Pan Tang, Juncheng Chen, Dan Zhang, Yang Li, Gaoxia Yang, Yun Liu, Yiwen Zhang, Yu-Xi Wang, Jie Liu, Liang Ouyang
Discovery of 4-Hydroxyquinazoline Derivatives as Small Molecular BET/PARP1 Inhibitors That Induce Defective Homologous Recombination and Lead to Synthetic Lethality for Triple-Negative Breast Cancer Therapy. Journal of medicinal chemistry 65 (9) (2022)
Yang Li, Gaoxia Yang, Jifa Zhang, Pan Tang, Chengcan Yang, Guan Wang, Juncheng Chen, Jie Liu, Lan Zhang, Liang Ouyang
Discovery, Synthesis, and Evaluation of Highly Selective Vascular Endothelial Growth Factor Receptor 3 (VEGFR3) Inhibitor for the Potential Treatment of Metastatic Triple-Negative Breast Cancer. Journal of medicinal chemistry 64 (16) (2021)
Yun-Mei Liu, Yang Li, Rong-Fang Liu, Jie Xiao, Bin-Ning Zhou, Qi-Zhi Zhang, Jian-Xin Song
Synthesis, characterization and preliminary biological evaluation of chrysin amino acid derivatives that induce apoptosis and EGFR downregulation. Journal of Asian natural products research 23 (1) (2019)